Mr. Speaker, our thoughts do go out to all those who suffer from MS.
Just this year, through CIHR, we have invested $5.4 million specifically for MS research. We are moving as quickly as possible, based on the best available science. We have established a scientific expert working group to monitor and analyze results from the seven MS Society-sponsored studies already under way in Canada and in the U.S. The terms of reference for this working group, along with the names of the Canadian members, are available on the CIHR website.
If the experts advise in favour of clinical trials, our government, working with the MS Society and provinces, like Saskatchewan and others, and the territories, will ensure they are funded.
We are committed to getting this right, but we really must get it right before we move ahead on something that we have some confidence will work. We do have to be sure.